ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AFMD Affimed NV

5.3152
0.3152 (6.30%)
Last Updated: 14:34:12
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Affimed NV AFMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.3152 6.30% 5.3152 14:34:12
Open Price Low Price High Price Close Price Prev Close
5.08 5.01 5.35 5.00
more quote information »

Recent News

Date Time Source Heading
3/28/202406:30GLOBEAffimed Reports 2023 Financial Results and Operational..
3/21/202406:30GLOBEAffimed To Report Full Year 2023 Financial Results &..
3/11/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/06/202406:34EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/06/202406:30GLOBEAffimed Announces 1-for-10 Reverse Stock Split
1/08/202416:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202416:05GLOBEAffimed Provides Clinical Response Update on AFM24-102 Trial..
1/08/202408:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202408:00GLOBEAffimed Announces Leadership Change and Organizational..
1/03/202406:30GLOBEAffimed Announces Sale of Wholly-Owned Subsidiary AbCheck
12/11/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202306:02GLOBEAffimed Announces Positive Data for AFM24 in Combination..
12/11/202306:00GLOBEAffimed Announces Updated Phase 1/2 Data from Acimtamig in..
12/04/202306:30GLOBEAffimed to Host Investor Conference Call Highlighting..
11/30/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/14/202306:30GLOBEAffimed Reports Third Quarter 2023 Financial Results and..
11/09/202306:30GLOBEAffimed Announces Acimtamig as International Nonproprietary..
11/07/202306:30GLOBEAffimed to Report Third Quarter 2023 Financial Results &..
11/03/202312:05GLOBEAffimed Presents Preclinical Data Showing that Addition of..
11/02/202309:05GLOBEAffimed Announces Oral Presentation of Phase 1/2 Data from..
11/01/202306:30GLOBEAffimed to Participate in Upcoming Investor Conferences
10/04/202306:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202306:30GLOBEAffimed Announces Listing Transfer to Nasdaq Capital Markets
9/27/202309:05GLOBEAffimed Announces Acceptance of an Abstract Comparing NK..
9/21/202306:30GLOBEAffimed to Present at the Cantor Global Healthcare..
9/12/202306:30GLOBEAffimed Receives FDA Fast Track Designation for AFM13 in..
9/07/202306:30GLOBEAffimed to Present at the H.C. Wainwright Annual Global..
8/22/202305:00GLOBEAffimed Announces Publication in the Journal mAbs on..
8/10/202306:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/10/202306:30GLOBEAffimed Reports Second Quarter 2023 Financial Results and..
8/03/202306:30GLOBEAffimed to Report Second Quarter 2023 Financial Results..
7/31/202317:05GLOBEAffimed Announces an ASCO Breakthrough Poster Presentation..
6/22/202306:30GLOBEAffimed Announces Addition of Dr. Constanze Ulmer-Eilfort to..
6/09/202317:59GLOBEAffimed Announces Acceptance of Abstracts at the 17th..
6/03/202309:00GLOBEAffimed Presents AFM24 Monotherapy Data in Non-Small Cell..
5/30/202306:30GLOBEAffimed to Present at the 2023 Jefferies Healthcare..
5/25/202317:00GLOBEAffimed Announces Publication of AFM24 Clinical Abstracts..
5/23/202306:30GLOBEAffimed Reports First Quarter 2023 Financial Results and..
5/23/202306:15GLOBEAffimed Announces IND Clearance for a Phase 2 Clinical Trial..
5/22/202306:30GLOBEAffimed Announces Annual General Meeting of Shareholders
5/16/202306:30GLOBEAffimed to Report First Quarter 2023 Financial Results &..
5/11/202310:05GLOBEAffimed Announces Abstracts at the Annual Meeting of the..
4/26/202310:00GLOBEAffimed Announces AFM24 Clinical Abstracts Accepted for the..

Your Recent History

Delayed Upgrade Clock